BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36281210)

  • 1. Inhaled Nitric Oxide in Acute Severe Pulmonary Hypertension and Severe Acute Respiratory Distress Syndrome Secondary to COVID-19 Pneumonia: A Case Report.
    Vives M; Gascó I; Pla G; Maciel JL; Ricart Hernandez A; Regí Roman K; Parramon F
    Am J Case Rep; 2022 Oct; 23():e937147. PubMed ID: 36281210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rescue inhaled nitric oxide on right ventricle and pulmonary circulation in severe COVID-related acute respiratory distress syndrome.
    Bonizzoli M; Lazzeri C; Cianchi G; Guetti C; Fulceri GE; Socci F; Peris A
    J Crit Care; 2022 Dec; 72():153987. PubMed ID: 35120777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
    Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
    Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of pulmonary blood flow in patients with acute respiratory failure.
    Spina S; Marrazzo F; Morais CCA; Victor M; Forlini C; Guarnieri M; Bastia L; Giudici R; Bassi G; Xin Y; Cereda M; Amato M; Langer T; Berra L; Fumagalli R
    Nitric Oxide; 2023 Jul; 136-137():1-7. PubMed ID: 37172929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile?
    Lotz C; Muellenbach RM; Meybohm P; Mutlak H; Lepper PM; Rolfes CB; Peivandi A; Stumpner J; Kredel M; Kranke P; Torje I; Reyher C
    Acta Anaesthesiol Scand; 2021 May; 65(5):629-632. PubMed ID: 33296498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications.
    Redaelli S; Pozzi M; Giani M; Magliocca A; Fumagalli R; Foti G; Berra L; Rezoagli E
    J Aerosol Med Pulm Drug Deliv; 2023 Jun; 36(3):112-126. PubMed ID: 37083488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent Right Ventricle Dilatation in SARS-CoV-2-Related Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation Support.
    Lazzeri C; Bonizzoli M; Batacchi S; Cianchi G; Franci N; Socci F; Peris A
    J Cardiothorac Vasc Anesth; 2022 Jul; 36(7):1956-1961. PubMed ID: 34538743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension.
    Feng WX; Yang Y; Wen J; Liu YX; Liu L; Feng C
    ESC Heart Fail; 2021 Feb; 8(1):714-718. PubMed ID: 33205620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.
    Gebistorf F; Karam O; Wetterslev J; Afshari A
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD002787. PubMed ID: 27347773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19.
    Matthews L; Baker L; Ferrari M; Sanchez W; Pappachan J; Grocott MP; Dushianthan A;
    J Intensive Care Med; 2022 Aug; 37(8):1101-1111. PubMed ID: 35369798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with acute respiratory distress syndrome.
    Kuhlen R; Walbert E; Fränkel P; Thaden S; Behrendt W; Rossaint R
    Intensive Care Med; 1999 Jul; 25(7):752-4. PubMed ID: 10470582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19.
    Laghlam D; Rahoual G; Malvy J; Estagnasié P; Brusset A; Squara P
    Front Med (Lausanne); 2021; 8():655763. PubMed ID: 34277653
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization.
    Caravita S; Baratto C; Di Marco F; Calabrese A; Balestrieri G; Russo F; Faini A; Soranna D; Perego GB; Badano LP; Grazioli L; Lorini FL; Parati G; Senni M
    Eur J Heart Fail; 2020 Dec; 22(12):2228-2237. PubMed ID: 33200458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Fixed-Dose Inhaled Epoprostenol and Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome in Critically Ill Adults.
    Buckley MS; Agarwal SK; Garcia-Orr R; Saggar R; MacLaren R
    J Intensive Care Med; 2021 Apr; 36(4):466-476. PubMed ID: 32133901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide in newborns with severe hypoxic respiratory failure.
    Chotigeat U; Khorana M; Kanjanapattanakul W
    J Med Assoc Thai; 2007 Feb; 90(2):266-71. PubMed ID: 17375630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic hypercapnia prevents inhaled nitric oxide-induced right-ventricular systolic dysfunction in juvenile rats.
    Dunlop K; Gosal K; Kantores C; Ivanovska J; Dhaliwal R; Desjardins JF; Connelly KA; Jain A; McNamara PJ; Jankov RP
    Free Radic Biol Med; 2014 Apr; 69():35-49. PubMed ID: 24423485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome.
    Nakagawa TA; Morris A; Gomez RJ; Johnston SJ; Sharkey PT; Zaritsky AL
    J Pediatr; 1997 Jul; 131(1 Pt 1):63-9. PubMed ID: 9255193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patients.
    Plazak W; Gryga K; Sznajd J; Wilisowska J; Czarnobilska E; Goncerz G; Podolec P; Musial J
    Clin Rheumatol; 2012 Jan; 31(1):99-104. PubMed ID: 21670950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of hemoglobin glutamer-200 and iNO on pulmonary vascular tone and arterial oxygenation in an experimental acute respiratory distress syndrome.
    Voelker MT; Bergmann A; Busch T; Jahn N; Laudi S; Noreikat K; Simon P; Bercker S
    Pulm Pharmacol Ther; 2018 Apr; 49():130-133. PubMed ID: 29425776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome.
    Gierhardt M; Pak O; Walmrath D; Seeger W; Grimminger F; Ghofrani HA; Weissmann N; Hecker M; Sommer N
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34526314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.